Eric Rougemond
Chief Executive Officer at PX Therapeutics SA
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Sébastien Aguettant | M | - |
Aguettant Sante SA
Aguettant Sante SA Pharmaceuticals: MajorHealth Technology Aguettant Sante SA manufactures and commercializes pharmaceutical products. The company was founded in 1954 and is headquartered in Lyon, France.
Laboratoire Aguettant SAS
Laboratoire Aguettant SAS Pharmaceuticals: MajorHealth Technology Laboratoire Aguettant SAS manufactures pharmaceutical products. It offers emergency medicines, micronutrition, Parkinson and pre-filled syringes. The company was founded by Georges Aguettant in 1941 and is headquartered in Lyon, France. | - |
Emmanuel Deruaz | M | - |
Laboratoire Aguettant SAS
Laboratoire Aguettant SAS Pharmaceuticals: MajorHealth Technology Laboratoire Aguettant SAS manufactures pharmaceutical products. It offers emergency medicines, micronutrition, Parkinson and pre-filled syringes. The company was founded by Georges Aguettant in 1941 and is headquartered in Lyon, France. | - |
Bernard Gilly | M | 67 |
PX Therapeutics SA
PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | - |
Bryan Geoffrey Morton | M | 67 |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | - |
Alain Benisty | M | 64 |
PX Therapeutics SA
PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | - |
Jean-François Peyroux | M | - |
Laboratoire Aguettant SAS
Laboratoire Aguettant SAS Pharmaceuticals: MajorHealth Technology Laboratoire Aguettant SAS manufactures pharmaceutical products. It offers emergency medicines, micronutrition, Parkinson and pre-filled syringes. The company was founded by Georges Aguettant in 1941 and is headquartered in Lyon, France. | - |
Martine Pagan | F | - |
Laboratoire Aguettant SAS
Laboratoire Aguettant SAS Pharmaceuticals: MajorHealth Technology Laboratoire Aguettant SAS manufactures pharmaceutical products. It offers emergency medicines, micronutrition, Parkinson and pre-filled syringes. The company was founded by Georges Aguettant in 1941 and is headquartered in Lyon, France. | - |
Melanie Gross | F | - |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | - |
Jacques Guardiola | M | - |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | - |
Raphael Herbinet | M | - |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | - |
Catherine Gorron | F | - |
Laboratoire Aguettant SAS
Laboratoire Aguettant SAS Pharmaceuticals: MajorHealth Technology Laboratoire Aguettant SAS manufactures pharmaceutical products. It offers emergency medicines, micronutrition, Parkinson and pre-filled syringes. The company was founded by Georges Aguettant in 1941 and is headquartered in Lyon, France. | - |
Guy Chatelain | M | - |
EUSA Pharma SAS
EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France. | - |
Benoit Arnaud | M | - |
Laboratoire Aguettant SAS
Laboratoire Aguettant SAS Pharmaceuticals: MajorHealth Technology Laboratoire Aguettant SAS manufactures pharmaceutical products. It offers emergency medicines, micronutrition, Parkinson and pre-filled syringes. The company was founded by Georges Aguettant in 1941 and is headquartered in Lyon, France. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Marc M. P. de Garidel | M | 66 |
PX Therapeutics SA
PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | - |
Claire Untereiner | F | - |
PX Therapeutics SA
PX Therapeutics SA Miscellaneous Commercial ServicesCommercial Services PX Therapeutics SA manufactures and develops recombinant proteins and monoclonal antibodies. Its services include protein engineering, optimization of drug candidates, humanization of antibodies, and production and release of GMP batches for clinical studies. The firm specializes in the field of in-vivo and in-vitro diagnostics, industrial enzymes, and ancillary products. The company was founded by Tristan Rousselle and Nicolas Mouz in November 2000 and is headquartered in Grenoble, France. | 10 years |
Statistics
Country | Connections | % of total |
---|---|---|
France | 15 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Rougemond
- Personal Network